Accelerating Medicines Partnership® SCHIZOPHRENIA
News and Updates
Keep up with the latest news about the Accelerating Medicines Partnership (AMP®) SCZ program.

Recruitment Updates


The target enrollment for the study is 2,617 individuals.

November 20, 2024: 2,153 individuals across 43 sites have completed screening and are in baseline or months 1 – 18.


Last Reviewed on November 20, 2024